Nearly 4 in 10 seniors have gotten a COVID-19 vaccine so far this year, new survey data published by the Centers for Disease Control and Prevention suggests, marking a steep increase in vaccination rates compared with the same time last year.
New findings from two studies have tied use of the antiviral drug nirmatrelvir-ritonavir (Paxlovid) to a reduction in COVID-19 hospitalizations and death, as well as to faster resolution of symptoms and less use of healthcare resources.
In the survey — the largest of its kind — most of the 16,000 respondents aged 16 to 25, from every state in the country, said they were worried about the impact climate change was having on humans and the planet, reported the Chicago Tribune.
